ID

12028

Descripción

Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01976962 Principal Investigator: Harvey Quon, MD CancerCare Manitoba

Link

https://clinicaltrials.gov/show/NCT01976962

Palabras clave

  1. 1/9/15 1/9/15 -
Subido en

1 de septiembre de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostatic Neoplasms NCT01976962

Eligibility Prostatic Neoplasms NCT01976962

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Informed consent
Descripción

Informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Age >18 years
Descripción

Age >18 years

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
Histologically confirmed and centrally reviewed prostate adenocarcinoma based
Descripción

Histologically confirmed and centrally reviewed prostate adenocarcinoma based

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007112
PSA within 60 days
Descripción

PSA within 60 days

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0138741
High risk prostate cancer defined as any one of: clinical stage >= T3, Gleason score >= 8, or PSA >=20 and <50 ng/mL.
Descripción

High risk prostate cancer defined as any one of: clinical stage >= T3, Gleason score >= 8, or PSA >=20 and <50 ng/mL.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0332167
UMLS CUI [2]
C0600139
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Evidence of lymph node metastasis
Descripción

Evidence of lymph node metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024204
UMLS CUI [2]
C0027627
Evidence of distant metastases
Descripción

Evidence of distant metastases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027627
UMLS CUI [2]
C0443203
Prior pelvic radiotherapy or brachytherapy
Descripción

Prior pelvic radiotherapy or brachytherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0436276
Previous radical prostatectomy, cryotherapy, or high-frequency ultrasound
Descripción

Previous radical prostatectomy, cryotherapy, or high-frequency ultrasound

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0033573
Unable to undergo gold seed insertion
Descripción

Unable to undergo gold seed insertion

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1960738
Immunosuppressive medications
Descripción

Immunosuppressive medications

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021081
Inflammatory bowel disease
Descripción

Inflammatory bowel disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021390
Unable to undergo MRI
Descripción

Unable to undergo MRI

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024485
Previous bilateral orchiectomy
Descripción

Previous bilateral orchiectomy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0029189
UMLS CUI [2]
C0238767
Previous hormonal therapy including LHRH agonists (leuprolide, goserelin), LHRH antagonists (degarelix), anti-androgens (bicalutamide, flutamide, nilutamide), surgical castration, and estrogens
Descripción

Previous hormonal therapy including LHRH agonists (leuprolide, goserelin), LHRH antagonists (degarelix), anti-androgens (bicalutamide, flutamide, nilutamide), surgical castration, and estrogens

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0279025
Previous finasteride within 14 days.
Descripción

Previous finasteride within 14 days.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0060389
Previous dutasteride within 180 days.
Descripción

Previous dutasteride within 180 days.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0754659

Similar models

Eligibility Prostatic Neoplasms NCT01976962

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
informed consent
Item
Informed consent
boolean
C0021430 (UMLS CUI [1])
age
Item
Age >18 years
boolean
C0001779 (UMLS CUI [1])
prostate adenocarcinoma
Item
Histologically confirmed and centrally reviewed prostate adenocarcinoma based
boolean
C0007112 (UMLS CUI [1])
psa
Item
PSA within 60 days
boolean
C0138741 (UMLS CUI [1])
high risk; Prostate carcinoma
Item
High risk prostate cancer defined as any one of: clinical stage >= T3, Gleason score >= 8, or PSA >=20 and <50 ng/mL.
boolean
C0332167 (UMLS CUI [1])
C0600139 (UMLS CUI [2])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
lymph nodes; metastasis
Item
Evidence of lymph node metastasis
boolean
C0024204 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
metastases; distant
Item
Evidence of distant metastases
boolean
C0027627 (UMLS CUI [1])
C0443203 (UMLS CUI [2])
pelvic radiotherapy
Item
Prior pelvic radiotherapy or brachytherapy
boolean
C0436276 (UMLS CUI [1])
prostatectomy
Item
Previous radical prostatectomy, cryotherapy, or high-frequency ultrasound
boolean
C0033573 (UMLS CUI [1])
Implantation of radioactive seed into prostate
Item
Unable to undergo gold seed insertion
boolean
C1960738 (UMLS CUI [1])
Immunosuppressive Agents
Item
Immunosuppressive medications
boolean
C0021081 (UMLS CUI [1])
Inflammatory bowel disease
Item
Inflammatory bowel disease
boolean
C0021390 (UMLS CUI [1])
mri
Item
Unable to undergo MRI
boolean
C0024485 (UMLS CUI [1])
orchiectomy; bilateral
Item
Previous bilateral orchiectomy
boolean
C0029189 (UMLS CUI [1])
C0238767 (UMLS CUI [2])
hormonal therapy
Item
Previous hormonal therapy including LHRH agonists (leuprolide, goserelin), LHRH antagonists (degarelix), anti-androgens (bicalutamide, flutamide, nilutamide), surgical castration, and estrogens
boolean
C0279025 (UMLS CUI [1])
finasteride
Item
Previous finasteride within 14 days.
boolean
C0060389 (UMLS CUI [1])
dutasteride
Item
Previous dutasteride within 180 days.
boolean
C0754659 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial